INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $238,726 | -6.2% | 5,854 | -14.2% | 0.01% | -22.2% |
| Q1 2023 | $254,405 | -30.5% | 6,826 | +4.3% | 0.01% | -47.1% |
| Q3 2022 | $366,000 | +12.6% | 6,546 | +4.4% | 0.02% | +13.3% |
| Q2 2022 | $325,000 | +16.1% | 6,272 | +63.0% | 0.02% | +7.1% |
| Q1 2022 | $280,000 | -4.1% | 3,848 | +55.6% | 0.01% | -17.6% |
| Q4 2021 | $292,000 | -40.5% | 2,473 | -32.4% | 0.02% | -61.4% |
| Q3 2021 | $491,000 | – | 3,659 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |